Onset of Atopic Comorbidities Relative to Atopic Dermatitis Diagnosis in a Real-World Setting Using an Israeli Claims DatabaseDecember 12th 2022
A 2022 RAD Conference abstract presentation showed the epidemiology of type 2 associated conditions included in patients with AD.
Boston Children’s Multidisciplinary Clinic’s Model for Adverse Mental Health Effects of ADDecember 12th 2022
At the 2022 RAD Conference, a Harvard University psychologist discusses ways that practitioners can help identify and treat children with adverse mental health outcomes as a result of atopic dermatitis.
Raj Chovatiya, MD, PhD, Discusses his Sessions at the Upcoming RAD ConferenceDecember 10th 2022
Raj Chovatiya, MD, PhD, gives a preview of his discussions on topical formulations of atopic dermatitis and advancing therapeutic expectations at this weekend’s RAD conference.
Mona Shahriari, MD, Looks Ahead to the RAD ConferenceDecember 9th 2022
Mona Shahriari, MD, Assistant Clinical Professor of Dermatology at Yale University School of Medicine, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.
Korey Capozza, MPH, Talks About What is Happening at the RAD ConferenceDecember 9th 2022
Korey Capozza, MPH, Executive Director of Global Parents for Eczema Research, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.
The Hidden Costs of Atopic DermatitisApril 13th 2022
Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research expands on her talk from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference is held from April 9 to 11 in Baltimore, Maryland.
Study: How Can Digital Therapeutic Interventions Improve Symptoms of Atopic Dermatitis?April 12th 2022
What role will digital therapeutic agents have in the coming years of atopic dermatitis treatment? It’s still being studied, but Jonathan Silverberg, MD, reviewed an interventional study that may provide key insights into what’s to come.
The Burden of Itch for Pediatric Patients and ParentsApril 12th 2022
Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research, explores the hidden burdens of itch that many pediatric patients and parents have to deal with on a daily basis. She expanded on her talk from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference was held from April 9 to 11 in Baltimore, Maryland
Study: Patients with High Accountability Have Better Adherence to AD TreatmentApril 11th 2022
In her talk at the Revolutionizing Atopic Dermatitis Conference, Madison Cook, BS, gives tips on how to increase accountability, common barriers to overcome with patients, and more.
Dupilumab's Impact on Quality of Life in Children 6 Months to 5 YearsApril 11th 2022
An abstract presented at the Revolutionizing Atopic Dermatitis conference discussed the impact of treatment with dupilumab on quality of life for children aged 6 months to 5 years with atopic dermatitis, as well as their caregivers.
On the Radar: Emerging Biologics, Topical Anti-Inflammatories, and Systemic Treatments for ADApril 10th 2022
Expert panelists discussed the pros, cons, and unknowns of the fast-growing roster of new AD treatments in a session at the 4th Annual Revolutionizing Atopic Dermatitis Conference held April 9 to 11, 2022 in Baltimore, Maryland.